Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CVAC | NASDAQ | USD | Real-time | |
1CVAC | Milan | EUR | Real-time | |
5CV | Stuttgart | EUR | Delayed | |
5CV | Xetra | EUR | Delayed | |
5CV | Frankfurt | EUR | Delayed | |
5CV | TradeGate | EUR | Delayed | |
CVAC | Vienna | EUR | Real-time |
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.
Name | Age | Since | Title |
---|---|---|---|
Baron Jean Stephenne | 72 | 2015 | Independent Chairman of Supervisory Board |
Michel De Wilde | 73 | 2016 | Member of Scientific Advisory Board |
Craig A. Tooman | 58 | 2019 | Supervisory Board Member |
Stanley A. Plotkin | 91 | 2016 | Member of Scientific Advisory Board |
Fred Zepp | - | 2016 | Member of Scientific Advisory Board |
Jean-Paul Prieels | - | 2016 | Member of Scientific Advisory Board |
Christopher Karp | - | 2016 | Member of Scientific Advisory Board |
Michael Brosnan | 69 | 2023 | Independent Director of Supervisory Board |
Klaus Schollmeier | 67 | 2022 | Supervisory Board Member |
Mathias P. Hothum | 57 | 2015 | Supervisory Board Member |
Michael P. Manns | - | 2016 | Member of Scientific Advisory Board |
Daniel Speiser | - | 2016 | Member of Scientific Advisory Board |
Nina Bhardwaj | - | 2016 | Member of Scientific Advisory Board |
Dirk Jäger | - | 2016 | Member of Scientific Advisory Board |
Karim Fizazi | 58 | 2016 | Member of Scientific Advisory Board |
Gerd Zettlmeissl | 69 | 2016 | Member of Scientific Advisory Board |
Viola Bronsema | 61 | 2020 | Supervisory Board Member |
Debra Barker | 62 | 2022 | Supervisory Board Member |
Xiao-Ning Xu | - | 2016 | Member of Scientific Advisory Board |
George R. Siber | 79 | 2016 | Member of Scientific Advisory Board |
Craig L. Slingluff | - | 2023 | Member of Scientific Advisory Board |
Hans-Georg Rammensee | - | 2001 | Scientific Director of Immunology and Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review